Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page footer revision version was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site version change rather than a change to the study record itself.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page's version history.SummaryDifference0.1%

- Check49 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated to v3.4.2 was added and the previous revision notice v3.4.1 along with the government-funding/operating status notice were removed.SummaryDifference0.5%

- Check85 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operation status guidance. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.